|
1
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e5. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Keegan KA, Schupp CW, Chamie K, Hellenthal
NJ, Evans CP and Koppie TM: Histopathology of surgically treated
renal cell carcinoma: Survival differences by subtype and stage. J
Urol. 188:391–397. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang L and Lee BR: Novel agents and
approaches for advanced renal cell carcinoma. J Urol.
188(716)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Capitanio U and Montorsi F: Renal cancer.
Lancet. 387:894–906. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu R, Su Y, Wu H, Dai Y, Zhao M and Lu Q:
Characters, functions and clinical perspectives of long non-coding
RNAs. Mol Genet Genomics. 291:1013–1033. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu G, Zhao X, Zhou J, Cheng X, Ye Z and
Ji Z: lncRNA TP73-AS1 promotes cell proliferation and inhibits cell
apoptosis in clear cell renal cell carcinoma through repressing
KISS1 expression and inactivation of PI3K/Akt/mTOR signaling
pathway. Cell Physiol Biochem. 48:371–384. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xiao H, Bao L, Xiao W, Ruan H, Song Z, Qu
Y, Chen K, Zhang X and Yang H: Long non-coding RNA Lucat1 is a poor
prognostic factor and demonstrates malignant biological behavior in
clear cell renal cell carcinoma. Oncotarget. 8:113622–113634.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zheng Z, Zhao F, Zhu D, Han J, Chen H, Cai
Y, Chen Z and Xie W: Long non-coding RNA LUCAT1 promotes
proliferation and invasion in clear cell renal cell carcinoma
through AKT/GSK-3β signaling pathway. Cell Physiol Biochem.
48:891–904. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang LN, Zhu XQ, Song XS and Xu Y: Long
noncoding RNA lung cancer associated transcript 1 promotes
proliferation and invasion of clear cell renal cell carcinoma cells
by negatively regulating miR-495-3p. J Cell Biochem. 119:7599–7609.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bartel DP: Metazoan microRNAs. Cell.
173:20–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
He YH, Chen C and Shi Z: The biological
roles and clinical implications of microRNAs in clear cell renal
cell carcinoma. J Cell Physiol. 233:4458–4465. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kang W, Huang T, Zhou Y, Zhang J, Lung
RWM, Tong JHM, Chan AWH, Zhang B, Wong CC, Wu F, et al: miR-375 is
involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in
gastric carcinogenesis. Cell Death Dis. 9(92)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ji CX, Fan YH, Xu F, Lv SG, Ye MH, Wu MJ,
Zhu XG and Wu L: MicroRNA-375 inhibits glioma cell proliferation
and migration by downregulating RWDD3 in vitro. Oncol Rep.
39:1825–1834. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu S, Song L, Yao H, Zhang L, Xu D, Gao F
and Li Q: miR-375 Is epigenetically downregulated by HPV-16 E6
mediated DNMT1 upregulation and modulates EMT of cervical cancer
cells by suppressing lncRNA MALAT1. PLoS One.
11(e0163460)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang J and Sun X: MicroRNA-375 inhibits
the proliferation, migration and invasion of kidney cancer cells by
triggering apoptosis and modulation of PDK1 expression. Environ
Toxicol Pharmacol. 62:227–233. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rybarczyk A, Klacz J, Wronska A,
Matuszewski M, Kmiec Z and Wierzbicki PM: Overexpression of the
YAP1 oncogene in clear cell renal cell carcinoma is associated with
poor outcome. Oncol Rep. 38:427–439. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xiao J, Shi Q, Li W, Mu X, Peng J, Li M,
Chen M, Huang H, Wang C, Gao K and Fan J: ARRDC1 and ARRDC3 act as
tumor suppressors in renal cell carcinoma by facilitating YAP1
degradation. Am J Cancer Res. 8:132–143. 2018.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gayed BA, Youssef RF, Bagrodia A, Kapur P,
Darwish OM, Krabbe LM, Sagalowsky A, Lotan Y and Margulis V:
Prognostic role of cell cycle and proliferative biomarkers in
patients with clear cell renal cell carcinoma. J Urol.
190:1662–1667. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Thai P, Statt S, Chen CH, Liang E,
Campbell C and Wu R: Characterization of a novel long noncoding
RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer
cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wieczorek E and Reszka E: MRNA, microRNA
and lncRNA as novel bladder tumor markers. Clin Chim Acta.
477:141–153. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G,
Zhao Q, Wu D, Gong W, Du M, et al: lncRNA MT1JP functions as a
ceRNA in regulating FBXW7 through competitively binding to
miR-92a-3p in gastric cancer. Mol Cancer. 17(87)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu XH, Wang J and Dong YH: The inhibitory
effect of miR-375 targeting sp1 in colorectal cancer cell
proliferation. Eur Rev Med Pharmacol Sci. 22:405–411.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang Y, Tang Q, Li M, Jiang S and Wang X:
MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Biochem Biophys Res Commun. 444:199–204. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cheng L, Zhan B, Luo P and Wang B:
miRNA375 regulates the cell survival and apoptosis of human
non-small cell carcinoma by targeting HER2. Mol Med Rep.
15:1387–1392. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Shi Y, Cao T, Sun Y, Xia J, Wang P and Ma
J: Nitidine Chloride inhibits cell proliferation and invasion via
downregulation of YAP expression in prostate cancer cells. Am J
Transl Res. 11:709–720. 2019.PubMed/NCBI
|
|
31
|
Zhou Z, Zhang HS, Zhang ZG, Sun HL, Liu
HY, Gou XM, Yu XY and Huang YH: Loss of HACE1 promotes colorectal
cancer cell migration via upregulation of YAP1. J Cell Physiol.
234:9663–9672. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yan H, Li H, Li P, Li X, Lin J, Zhu L,
Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1
promotes ovarian cancer cells progression by modulating
miR-375/YAP1 axis. J Exp Clin Cancer Res. 37(237)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu G, Huang K, Jie Z, Wu Y, Chen J, Chen
Z, Fang X and Shen S: CircFAT1 sponges miR-375 to promote the
expression of Yes-associated protein 1 in osteosarcoma cells. Mol
Cancer. 17(170)2018.PubMed/NCBI View Article : Google Scholar
|
